S. Komatsu

Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-&kgr;B Activation

T. Yanase, K. Nabeshima, T. Nomiyama, 2017, Endocrinology.

SGLT2 Inhibitor Ipragliflozin Induces Breast Cancer Apoptosis via Membrane Hyperpolarization and Mitochondria Dysfunction

T. Yanase, T. Numata, T. Nomiyama, 2018, Diabetes.

Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-&kgr;B Activation

T. Yanase, K. Nabeshima, T. Nomiyama, 2017, Endocrinology.

SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation.

T. Yanase, T. Numata, T. Nomiyama, 2019, Endocrine journal.